FALCHETTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.355
EU - Europa 5.125
AS - Asia 3.079
SA - Sud America 363
AF - Africa 94
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.287
RU - Federazione Russa 1.639
SG - Singapore 874
IT - Italia 817
PL - Polonia 792
CN - Cina 648
HK - Hong Kong 638
SE - Svezia 523
IE - Irlanda 376
VN - Vietnam 324
BR - Brasile 302
DE - Germania 248
UA - Ucraina 237
KR - Corea 210
FR - Francia 148
FI - Finlandia 142
IN - India 118
GB - Regno Unito 111
AU - Australia 70
TR - Turchia 50
JO - Giordania 45
CA - Canada 29
BD - Bangladesh 28
AR - Argentina 26
BE - Belgio 23
IQ - Iraq 23
JP - Giappone 21
PK - Pakistan 20
NG - Nigeria 19
ES - Italia 17
SC - Seychelles 17
MX - Messico 16
ZA - Sudafrica 14
ID - Indonesia 12
UZ - Uzbekistan 11
CI - Costa d'Avorio 10
CO - Colombia 10
NL - Olanda 10
CH - Svizzera 9
KE - Kenya 8
MA - Marocco 8
RO - Romania 8
EU - Europa 7
IL - Israele 7
JM - Giamaica 7
SA - Arabia Saudita 7
EG - Egitto 6
KZ - Kazakistan 6
BO - Bolivia 5
CL - Cile 5
EC - Ecuador 5
LT - Lituania 5
UY - Uruguay 5
AL - Albania 4
AT - Austria 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IR - Iran 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
VE - Venezuela 3
AO - Angola 2
BG - Bulgaria 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
MM - Myanmar 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ML - Mali 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PW - Palau 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 16.095
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.550
Warsaw 792
Ashburn 664
Fairfield 604
Singapore 554
Hong Kong 549
Chandler 487
Jacksonville 403
Dublin 373
Woodbridge 281
Cambridge 271
Seattle 247
Wilmington 230
Seoul 208
Houston 201
San Jose 174
Beijing 169
Ann Arbor 164
Milan 155
The Dalles 124
Buffalo 119
Ho Chi Minh City 119
Lawrence 113
Altamura 111
Princeton 97
Hefei 88
Los Angeles 83
Lauterbourg 76
Munich 72
Boardman 68
Boston 66
Melbourne 63
Rome 61
Hanoi 60
Mumbai 56
Medford 55
Moscow 54
Shanghai 49
New York 46
Dallas 44
Florence 43
Paris 41
Kent 38
Pune 32
San Diego 32
Council Bluffs 31
Izmir 31
Norwalk 28
Helsinki 26
Brussels 23
São Paulo 23
Tokyo 21
Turku 21
Turin 19
Abuja 16
Baghdad 15
Da Nang 13
Frankfurt am Main 13
Haiphong 13
Naples 13
Andover 12
Guangzhou 12
Palermo 12
Rio de Janeiro 12
Brooklyn 11
Frankfurt Am Main 11
London 11
Miano 11
Orem 11
Abidjan 10
Dong Ket 10
Stockholm 10
Tianjin 10
Verona 10
Manchester 9
Tashkent 9
Toronto 9
Bern 8
Bologna 8
Chicago 8
Denver 8
Hillsboro 8
Johannesburg 8
Montreal 8
West Jordan 8
Yubileyny 8
Auburn Hills 7
Curitiba 7
Falls Church 7
Genoa 7
Hải Dương 7
Jakarta 7
Nairobi 7
Phoenix 7
Amman 6
Bari 6
Belo Horizonte 6
Chennai 6
Duncan 6
Kingston 6
Totale 10.536
Salva come PNG Salva come JPEG
Nome #
Multiple endocrine neoplasia type 1. 344
Multiple Endocrine Neoplasia Type 2. 326
Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study. 324
Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family. 283
Thyroid cancer: current molecular perspectives. 272
“Performance Improvements of Gas Injection Plant Using Inlet Air Cooling Systems”, 268
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. 263
Telomerase repeat amplificationprotocol (TRAP): A new molecular marker for parathyroid carcinoma. 225
Characterization and function of the receptor for IGF-I in human preosteoclastic cells. 217
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 214
The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. 214
FokI polymorphism at translation initiationsite of the vitamin D receptor gene predicts bone mineral density and vertebralfractures in postmenopausal Italian women. 213
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. 206
Polymorphism of the Aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. 203
Analysis of estrogen receptor (ERalpha and ERbeta and progesterone receptor (PR) polymorphisms in uterine leiomyomas. 201
AZIDOTHYMIDINE INDUCES APOPTOSIS AND INHIBITS CELL GROWTH AND TELOMERASE ACTIVITY OF HUMAN PARATHYROID CANCER IN CELL CULTURE 196
Calcium bioavailability from a calcium-rich mineral water, with some observations on method. 194
Allelic loss in parathyroid tumors from individualshomozygous for multiple endocrine neoplasia type 1. 194
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. 194
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 193
A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis 192
Evidence for bioeffects of LY 139478 on the human pre-osteoclasticcell line FLG 29.1. 191
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes 190
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. 189
Microencapsulation of human parathyroid cells:an "in vitro" study. 187
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components 185
MEN1 gene mutation analysis in Italian patients with multiple endocrineneoplasia type 1. 185
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 184
Multiple endocrine neoplasms 179
The role of osteoprogesterin (OPG) and estrogen receptor (ERα) gene polymorphism. 177
LRP5 gene polymorphism and cortical bone. 177
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? 176
Surgical approach in hereditary hyperparathyroidism. 173
Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. 172
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. 172
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. 171
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. 171
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy sindrome (APECED): report on three cases from Southern Italy. 167
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma. 167
Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw. 166
Genetic Epidemiology of Paget's Disease of Bone in Italy: sequestosome1/p62 Gene Mutational Test and Haplotype Analysis at 5q35 in a Large Representative Series of Sporadic and Familial Italian Cases of Paget's Disease of Bone. 165
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. 165
ALLELIC LOSS AT THE VITAMIN D RECEPTOR (VDR) LOCUS IN PARATHYROID TISSUE FROM ONE PATIENT AFFECTED BY REFRACTORY UREMIC HYPERPARATTHYROIDISM 163
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis 163
Osteoporotic patient course after surgical treatment with hip prosthesis 162
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients. 161
Mutations In Galnt3 Gene: Two Cases of Tumoral Calcinosis-hyperphosphatemia 161
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders. 158
Paget's disease of bone: there's more than the affected skeletal--a clinical review and suggestions for the clinical practice. 157
Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. 155
MEN1 family with a novel frameshift mutation. 154
The role of osteoprotegerin (OPG) and estrogen receptor (ER-α) gene polymorphisms in rheumatoid arthritis. 154
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. 154
Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia 154
Molecular diagnosis of parathyroid carcinoma: a reality in the near future. 153
HPE cells: a clonal endothelial cell line established from human parathyroid tissue (human parathyroid cell line). 152
Clonal analysis by chromosome 11 microsatellite-PCR ofmicrodissected parathyroid tumors from MEN 1 patients. 151
Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. 150
Dynamic investigation for evaluation of calcium metabolism and parathyroid function. 149
Somatic mutation analysis of the MEN1 gene in adrenocortical tumors using denaturing gradient gel electrophoresis (DGGE). 148
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. 148
Genetic polymorphisms in uremic secondary hyperparathyroidism. 148
CONSENSUS STATEMENT ON DIAGNOSIS OF PRIMARY HYPERCALCIURIA 147
Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women 147
Evidence of linkage disequilibrium between polymorphisms in the human estrogen receptor alfa gene and their relationship to bone mass variation in postmenopausal Italian women 143
Genetic polymorphisms in uremic secondary hyperparathyroidism. A multicentric Italian study 141
Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome. 141
Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? 141
Phytoestrogen: food or drug? 141
Fracture unit: a (possible) model of implementation in Italy. 140
Genetic polymorphisms of vitamin D receptor and calcium sensing receptor gene in uremic secondary hyperparathyroidism: a multicentric italian study 139
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. 139
Efficacy of Cinacalcet Therapy In Patients Affected By Primary Hyperparathyroidism Associated To Multiple Endocrine Neoplasia Syndrome Type 1 (men1): Preliminary Results of the Florentine Study 138
Characterisation of a Non-UBA Domain Missense Mutation of Sequestosome 1 (SQSTM1) in Paget's Disease of Bone. 138
Genetics of osteoporosis: role of steroid hormone receptor gene polymoprhisms. 136
Genotype-Phenotype Correlation Analyses in an Italian MEN1 Series. MEN1 Gene Mutational Performed at the Center for Hereditary Endocrine Tumors of Florence 135
Genetics and pharmacogenetics of osteoporosis 133
Genetic markers of osteoarticular disorders: facts and hopes. 132
Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias 132
GENETICS OF PRIMARY HYPERPARATHYROIDISM 131
Relationship of Volumetric Bone Mineral Density and Structural Parameters with ERα Gene Polymorphisms. 127
Molecular genetic analysis in the diagnosis of humoral calcinosis 123
Genetic aspects of the Paget's disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application. 121
Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin. 120
Genetica dell’Osteoporosi 113
Osteogenesis Imperfecta: Realization of A Multidisciplinar Network To Improve Information, Expertise and Resources 112
Guidelines for diagnosis and therapy of MEN type 1 and type 2. 110
Homozygotes for the autosomal dominant neoplasia syndrome (MEN1). 104
The vitamin D receptor: biological and molecular properties. 103
FokI Polymorphisms of the Vitamin D Receptor Gene Correlates with Parameters of Bone Mass and Turnover in a Female Population of the Italian Island of Lampedusa. 103
RFLP analysis of human chromosome 11 region q13in multiple symmetric lipomatosis and multiple endocrine neoplasia type1-associated lipomas. 100
What Is The Relationship Between Paget’s Disease of Bone and Hyperparathyroidism. 97
Gene mutations in Multiple Endocrine Neoplasia Type 1. 97
Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) genelocus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with theMEN-1 syndrome 95
Results of a national survey on multiple endocrine neoplasia syndrome type1 in Italy: a macroaggregate analysis. 94
Hereditary hyperparathyroidism. 93
Multiple endocrine neoplasia type 2 syndromes (MEN 2): resultsfrom the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 90
Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) 79
Totale 16.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 0 114
2021/2022729 32 104 31 38 33 21 44 52 25 18 176 155
2022/20231.792 170 385 72 153 144 320 221 74 177 13 42 21
2023/2024618 41 72 103 26 50 89 16 162 6 10 29 14
2024/20254.598 128 460 333 672 1.400 509 101 392 219 121 153 110
2025/20264.014 546 619 269 178 514 182 511 157 212 252 63 511
Totale 16.115